These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25107419)

  • 21. High dosage of aripiprazole-induced dysphagia.
    Lin TW; Lee BS; Liao YC; Chiu NY; Hsu WY
    Int J Eat Disord; 2012 Mar; 45(2):305-6. PubMed ID: 21541978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Agitation associated with aripiprazole initiation.
    Lea JW; Stoner SC; Lafollette J
    Pharmacotherapy; 2007 Sep; 27(9):1339-42. PubMed ID: 17723088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
    Lu ML; Shen WW; Chen CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial.
    McElroy SL; Suppes T; Frye MA; Altshuler LL; Stanford K; Martens B; Leverich GS; Post RM; Keck PE
    J Affect Disord; 2007 Aug; 101(1-3):275-81. PubMed ID: 17229469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aripiprazole-induced rabbit syndrome: a case report.
    Caykoylu A; Ekinci O; Kuloglu M; Deniz O
    J Psychopharmacol; 2010 Mar; 24(3):429-31. PubMed ID: 18957477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Aripiprazole induced Parkinsonism: A case report].
    Pasquier de Franclieu S; Germain C; Petitjean F
    Encephale; 2009 Oct; 35(5):496-8. PubMed ID: 19853725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Aripiprazole-induced parkinsonism in a 64-year-old female patient diagnosed with bipolar disorder].
    De Schutter P; Bouckaert F; Peuskens J
    Tijdschr Psychiatr; 2011; 53(5):299-303. PubMed ID: 21538299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Aripiprazole: a new atypical antipsychotic drug].
    Fischer B; Davids E; Gastpar M
    Fortschr Neurol Psychiatr; 2004 Sep; 72(9):497-502. PubMed ID: 15365912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperprolactinemia with aripiprazole: understanding the paradox.
    Saraf G; Behere RV; Venkatasubramanian G; Rao NP; Varambally S; Gangadhar BN
    Am J Ther; 2014; 21(3):e80-1. PubMed ID: 22357167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aripiprazole: a review of its pharmacology and clinical use.
    Taylor DM
    Int J Clin Pract; 2003; 57(1):49-54. PubMed ID: 12587943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine: case report and review of the literature.
    Ono S; Suzuki Y; Shindo M; Endo T; Fukui N; Sugai T; Someya T
    J Clin Pharm Ther; 2012 Jun; 37(3):370-2. PubMed ID: 22023382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
    Stip E; Tourjman V
    Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of aripiprazole and tardive dyskinesia.
    Abbasian C; Power P
    J Psychopharmacol; 2009 Mar; 23(2):214-5. PubMed ID: 18515468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Symptomatic bradycardia with oral aripiprazole and oral ziprasidone.
    Snarr BS; Phan SV; Garner A; VandenBerg AM; Barth KS
    Ann Pharmacother; 2010 Apr; 44(4):760-3. PubMed ID: 20215494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetic ketoacidosis associated with aripiprazole.
    Church CO; Stevens DL; Fugate SE
    Diabet Med; 2005 Oct; 22(10):1440-3. PubMed ID: 16176209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Torsades de pointes after administration of low-dose aripiprazole.
    Nelson S; Leung JG
    Ann Pharmacother; 2013 Feb; 47(2):e11. PubMed ID: 23362038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aripiprazole associated urine retention in a male schizophrenia patient.
    Hsu WY; Chang TG; Chiu NY
    Gen Hosp Psychiatry; 2013; 35(6):680.e11-2. PubMed ID: 23932666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tardive dyskinesia and other movement disorders secondary to aripiprazole.
    Peña MS; Yaltho TC; Jankovic J
    Mov Disord; 2011 Jan; 26(1):147-52. PubMed ID: 20818603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe exacerbation of psychosis after sudden withdrawal of chlorpromazine in the treatment of methamphetamine-associated psychosis with aripiprazole and chlorpromazine: 2 case reports.
    Wang G; Devi Thakoor JP; Wang X; Hao W
    J Addict Med; 2014; 8(6):479-81. PubMed ID: 25303986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole.
    Potkin SG; Raoufinia A; Mallikaarjun S; Bricmont P; Peters-Strickland T; Kasper W; Baker RA; Eramo A; Sanchez R; McQuade R
    Curr Med Res Opin; 2013 Oct; 29(10):1241-51. PubMed ID: 23822566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.